The complexities of the pathology-pathogenesis relationship in Alzheimer disease

被引:77
作者
Castellani, Rudy J. [1 ]
Perry, George [2 ]
机构
[1] Univ Maryland, Sch Med, Div Neuropathol, Baltimore, MD 21201 USA
[2] Univ Texas San Antonio, Coll Sci, San Antonio, TX USA
关键词
Alzheimer disease; Senile plaque; Neurofibrillary tangle; Amyloid-beta; Tau; Pathogenesis; NEUROPATHOLOGIC ASSESSMENT; BRAIN; DEMENTIA; PROTEIN; RADIOPHARMACEUTICALS; ASSOCIATION; MUTATIONS; A-BETA-42; PRECURSOR; AGE;
D O I
10.1016/j.bcp.2014.01.009
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Current pathogenic theories for Alzheimer disease (AD) and aging favor the notion that lesions and their constituent proteins are the initiators of disease due to toxicity. Whether this is because structural pathology is traditionally viewed as deleterious, and whether this, in turn, is a fundamental misinterpretation of the relationship between pathology and pathogenesis across the spectrum of chronic diseases, remains to be determined. As more and more detailed information about the biochemical constituents of AD lesions becomes available, it may also be argued that just as much knowledge of cellular physiology as pathophysiology has been gained. Indeed, essentially all major proteins in AD lesions are derived from molecular cascades, which are in turn highly conserved across cells, tissues, and species. Moreover, the lesions themselves are observed in the cognitively intact, and sometimes in large numbers, while major consensus criteria indicate that an extent of pathology is normal with advanced age. As the medical science community continues to pursue lesion targeting for therapeutic purposes, the notion that AD pathology is indicative of an active host response or environmental adaptation, and therefore a poor target, is becoming clearer. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:671 / 676
页数:6
相关论文
共 47 条
[1]   Four-dimensional multiphoton imaging of brain entry, amyloid binding, and clearance of an amyloid-β ligand in transgenic mice [J].
Bacskai, BJ ;
Hickey, GA ;
Skoch, J ;
Kajdasz, ST ;
Wang, YM ;
Huang, GF ;
Mathis, CA ;
Klunk, WE ;
Hyman, BT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (21) :12462-12467
[2]   Clinicopathologic studies in cognitively healthy aging and Alzheimer disease - Relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype [J].
Berg, L ;
McKeel, DW ;
Miller, JP ;
Storandt, M ;
Rubin, EH ;
Morris, JC ;
Baty, J ;
Coats, M ;
Norton, J ;
Goate, AM ;
Price, JL ;
Gearing, M ;
Mirra, SS ;
Saunders, AM .
ARCHIVES OF NEUROLOGY, 1998, 55 (03) :326-335
[3]   ASSOCIATION BETWEEN QUANTITATIVE MEASURES OF DEMENTIA AND OF SENILE CHANGE IN CEREBRAL GREY MATTER OF ELDERLY SUBJECTS [J].
BLESSED, G ;
TOMLINSON, BE ;
ROTH, M .
BRITISH JOURNAL OF PSYCHIATRY, 1968, 114 (512) :797-+
[4]  
Blocq P., 1892, SEMAINE M DICALE, V12, P445
[5]   NEUROPATHOLOGICAL STAGING OF ALZHEIMER-RELATED CHANGES [J].
BRAAK, H ;
BRAAK, E .
ACTA NEUROPATHOLOGICA, 1991, 82 (04) :239-259
[6]   Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years [J].
Braak, Heiko ;
Thal, Dietmar R. ;
Ghebremedhin, Estifanos ;
Del Tredici, Kelly .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2011, 70 (11) :960-969
[7]   Neuropathological Correlates of Dementia in Over-80-Year-Old Brain Donors from the Population-Based Cambridge City over-75s Cohort (CC75C) Study [J].
Brayne, Carol ;
Richardson, Kathryn ;
Matthews, Fiona E. ;
Fleming, Jane ;
Hunter, Sally ;
Xuereb, John H. ;
Paykel, Eugene ;
Mukaetova-Ladinska, Elizabeta B. ;
Huppert, Felicia A. ;
O'Sullivan, Angela ;
Dening, Tom .
JOURNAL OF ALZHEIMERS DISEASE, 2009, 18 (03) :645-658
[8]   Alzheimer's disease with spastic paraparesis and 'cotton wool' plaques: two pedigrees with PS-1 exon 9 deletions [J].
Brooks, WS ;
Kwok, JBJ ;
Kril, JJ ;
Broe, GA ;
Blumbergs, PC ;
Tannenberg, AE ;
Lamont, PJ ;
Hedges, P ;
Schofield, PR .
BRAIN, 2003, 126 :783-791
[9]  
Castellani R, 2014, C SERIES NEUROBIOLOG
[10]   Pathogenesis and Disease-modifying Therapy in Alzheimer's Disease: The Flat Line of Progress [J].
Castellani, Rudy J. ;
Perry, George .
ARCHIVES OF MEDICAL RESEARCH, 2012, 43 (08) :694-698